# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-23-001518
Filing Date
2023-01-09
Accepted
2023-01-09 08:38:57
Documents
50
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea171401-8k_relmada.htm iXBRL | 8-K | 30038
2 | PRESS RELEASE ISSUED ON JANUARY 9, 2023 | ea171401ex99-1_relmada.htm | EX-99.1 | 9304
3 | CORPORATE PRESENTATION DATED JANUARY 9, 2023 | ea171401ex99-2_relmada.htm | EX-99.2 | 49830
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 6617
5 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 71235
6 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 169341
7 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 70215
8 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 59074
9 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 99390
10 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 65201
11 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 123099
12 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 59351
13 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 106050
14 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 90829
15 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 79491
16 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 106761
17 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 95288
18 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 58149
19 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 109840
20 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 80887
21 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 87776
22 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 84793
23 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 80633
24 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 98619
25 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 91982
26 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 93912
27 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 87232
28 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 90053
29 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 97207
30 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 131803
31 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 125917
32 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 96655
33 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 79243
34 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 44893
35 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 82376
36 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 43505
37 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 57762
38 | GRAPHIC | ex99-2_034.jpg | GRAPHIC | 110422
39 | GRAPHIC | ex99-2_035.jpg | GRAPHIC | 28205
| Complete submission text file | 0001213900-23-001518.txt |  | 4504554

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
40 | XBRL SCHEMA FILE | rlmd-20230109.xsd | EX-101.SCH | 3224
41 | XBRL LABEL FILE | rlmd-20230109_lab.xml | EX-101.LAB | 34240
42 | XBRL PRESENTATION FILE | rlmd-20230109_pre.xml | EX-101.PRE | 22357
44 | EXTRACTED XBRL INSTANCE DOCUMENT | ea171401-8k_relmada_htm.xml | XML | 3614

Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 23516769
SIC: 2834 Pharmaceutical Preparations